{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T18:09:24Z","timestamp":1781114964922,"version":"3.54.1"},"reference-count":72,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cervical cancer due to high-risk human papillomavirus (HR-HPV) is the leading gynecological cancer in Sub-Saharan Africa and in the Democratic Republic of the Congo (DRC), where approximately one-quarter of people carries the sickle cell allele. This study aims to identify the HR-HPV genotypes and factors associated with major cervical abnormalities among women living in the sickle cell endemic area of Kisangani, DRC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      This hospital-based cross-sectional study consisted to a face-to-face and semi-structured questionnaire for collecting data of the socio-demographic, clinical and sexual behaviors characteristics of participants. The sickle cell status was confirmed using liquid chromatography coupled with mass spectrometry. Cervical smears were collected using the ThinPrep\n                      <jats:sup>\u00ae<\/jats:sup>\n                      Pap-test solution (Hologic Inc, Marlborough, USA). The HR-HPV molecular analysis was performed using the Cobas\n                      <jats:sup>\u00ae<\/jats:sup>\n                      6800 system (Roche Molecular Systems, Somerville, USA) for real time polymerase chain reaction (RT-PCR) and the Oxford Nanopore platform (Oxford Nanopore Technologies, Oxford, England) for the viral genome sequencing. Cytological analyses were performed using the ThinPrep 5000 processor (Hologic), and the results were reported according to the 2014 Bethesda System classification. The logistic regression model was used to estimate the adjusted Odd ratio (aOR) during the risk factor assessments.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 712 women enrolled, the prevalence of HR-HPV was 28.4% (95% CI: 25.1\u201331.7). HPV35, HPV52 and HPV31 were the most common genotypes; while the sequencing identified two new variants of HPV103 and HPV223. The following factors were associated with HR-HPV infection: (i) age between 25 and 34 years (aOR: 2.10, 95% CI:1.22\u20133.69); (ii) being unmarried (aOR: 1.54, 95% CI: 1.05\u20132.27) and (iii) HIV-positive status (aOR: 14.85, 95% CI: 2.36\u2013288.25). No correlation was observed between hemoglobin AS (HbAS) status and HR-HPV infection or cytological abnormalities. However, women aged 45\u201354 years (aOR: 3.8, 95% CI: 1.34\u201311.65), those using intravaginal herbal (aOR: 3.59, 95% CI: 1.26\u201311.28) and those infected with HPV33 (aOR: 8.45, 95% CI: 1.68\u201334.05) were more likely to present major cervical abnormalities in our series.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our study shows a high prevalence of cervical HR-HPV infection in Kisangani, DRC. HPV35, HPV52, and HPV31 are the three most common genotypes, while novel variants of HPV types 103 and 223 were identified. Our findings also highlight that advanced age, HPV33 infection and intravaginal herbal use are the main factors associated with major cervical abnormalities. Although HbAS has not been associated with HR-HPV infection or cervical lesions, further studies are needed to determine this association in women with sickle cell disease (HbSS).<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0350982","type":"journal-article","created":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T17:33:51Z","timestamp":1781112831000},"page":"e0350982","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Human papillomavirus genotypes and factors associated with major cervical smear abnormalities in a sickle cell endemic area of Kisangani, Democratic Republic of the Congo"],"prefix":"10.1371","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8132-4482","authenticated-orcid":true,"given":"Yvette","family":"Neema Ufoy Mungu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00eblle","family":"Desreux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elettra","family":"Bianchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burubu Lisi-Ankiene","family":"Junior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland Marini","family":"Djang\u2019eing\u2019a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Durkin","family":"Keith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Artesi","family":"Maria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katenga","family":"Bosunga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Bours","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,6,10]]},"reference":[{"key":"pone.0350982.ref001","doi-asserted-by":"crossref","first-page":"805695","DOI":"10.3389\/fimmu.2021.805695","article-title":"An update on human papilloma virus vaccines: history, types, protection, and efficacy","volume":"12","author":"Z Yousefi","year":"2021","journal-title":"Frontiers in Immunology"},{"issue":"4","key":"pone.0350982.ref002","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.semradonc.2021.04.001","article-title":"Epidemiology of HPV related malignancies","volume":"31","author":"N Scott-Wittenborn","year":"2021","journal-title":"Semin Radiat Oncol"},{"key":"pone.0350982.ref003","doi-asserted-by":"crossref","first-page":"1440480","DOI":"10.3389\/fpubh.2024.1440480","article-title":"Epidemiology and genotypes analysis of human papillomavirus infection in Huizhou, China","volume":"12","author":"Z Shu","year":"2024","journal-title":"Front Public Health"},{"issue":"3","key":"pone.0350982.ref004","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"F Bray","year":"2024","journal-title":"CA: A Cancer J Clinicians"},{"key":"pone.0350982.ref005","unstructured":"OMS\u00a0RDC. Faire progresser la lutte contre le cancer du col ut\u00e9rin en R\u00e9publique D\u00e9mocratique du Congo. 2024. https:\/\/www.afro.who.int\/fr\/countries\/democratic-republic-of-congo\/news\/faire-progresser-la-lutte-contre-le-cancer-du-col-de-luterus-en-republique-democratique-du-congo"},{"key":"pone.0350982.ref006","volume-title":"Human papillomavirus and related diseases in Democratic Republic of the Congo","author":"L Bruni","year":"2023"},{"issue":"12","key":"pone.0350982.ref007","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1086\/657321","article-title":"Cervical human papillomavirus prevalence in 5 continents: meta\u2010analysis of 1 million women with normal cytological findings","volume":"202","author":"L Bruni","year":"2010","journal-title":"J Infect Dis"},{"key":"pone.0350982.ref008","doi-asserted-by":"crossref","first-page":"552028","DOI":"10.3389\/fpubh.2020.552028","article-title":"Epidemiology and burden of human papillomavirus and related diseases, molecular pathogenesis, and vaccine evaluation","volume":"8","author":"AJ Kombe Kombe","year":"2021","journal-title":"Front Public Health"},{"key":"pone.0350982.ref009","unstructured":"Bruni L, Albero G, Serrano B, Mena M, Collado JJ, G\u00f3mez D, et al. Human Papillomavirus and Related Diseases in the World. 2023. https:\/\/hpvcentre.net\/datastatistics.php"},{"issue":"9490","key":"pone.0350982.ref010","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/S0140-6736(05)67069-9","article-title":"Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis","volume":"366","author":"GM Clifford","year":"2005","journal-title":"Lancet"},{"issue":"1","key":"pone.0350982.ref011","article-title":"Prevalence of human papillomavirus genotypes and precancerous cervical lesions in a screening population in the Republic of Korea, 2014\u20132016","volume":"29","author":"YT Ouh","year":"2018","journal-title":"J Gynecol Oncol"},{"issue":"7","key":"pone.0350982.ref012","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.3390\/v13071342","article-title":"Multiple Human Papilloma Virus (HPV) infections are associated with HSIL and persistent HPV infection status in Korean patients","volume":"13","author":"M Kim","year":"2021","journal-title":"Viruses"},{"issue":"1","key":"pone.0350982.ref013","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s43046-023-00196-x","article-title":"Distribution of high- and low-risk human papillomavirus genotypes and their prophylactic vaccination coverage among West African women: systematic review","volume":"35","author":"RA Ouedraogo","year":"2023","journal-title":"J Egypt Natl Canc Inst"},{"issue":"2","key":"pone.0350982.ref014","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/s41579-021-00617-5","article-title":"Human papillomaviruses: diversity, infection and host interactions","volume":"20","author":"AA McBride","year":"2022","journal-title":"Nat Rev Microbiol"},{"issue":"5","key":"pone.0350982.ref015","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/nrc798","article-title":"Papillomaviruses and cancer: from basic studies to clinical application","volume":"2","author":"H zur Hausen","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"pone.0350982.ref016","volume-title":"Global strategy to accelerate the elimination of cervical cancer as a public health problem","author":"World Health Organization","year":"2020","edition":"1"},{"issue":"9","key":"pone.0350982.ref017","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.molmed.2024.05.009","article-title":"HPV integration and cervical cancer: a failed evolutionary viral trait","volume":"30","author":"MA Molina","year":"2024","journal-title":"Trends Mol Med"},{"key":"pone.0350982.ref018","volume-title":"Clinical guidance: supporting the introduction of the HPV test in cervical cancer screening in Belgium","author":"C Simoens","year":"2024"},{"key":"pone.0350982.ref019","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/ncomms1104","article-title":"Global distribution of the sickle cell gene and geographical confirmation of the malaria hypothesis","volume":"1","author":"FB Piel","year":"2010","journal-title":"Nat Commun"},{"key":"pone.0350982.ref020","volume-title":"Guide pratique de diagnostic pr\u00e9coce et de prise en charge de la dr\u00e9panocytose en Afrique","author":"L Tshilolo","year":"2009"},{"issue":"02","key":"pone.0350982.ref021","doi-asserted-by":"crossref","first-page":"202","DOI":"10.4236\/jbm.2025.132016","article-title":"Sickle cell trait in Kisangani: prevalence and opinion of carriers towards the choice of a potential carrier spouse","volume":"13","author":"JLA Burubu","year":"2025","journal-title":"JBM"},{"issue":"20","key":"pone.0350982.ref022","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1001\/jama.2014.15063","article-title":"Association of sickle cell trait with chronic kidney disease and albuminuria in African Americans","volume":"312","author":"RP Naik","year":"2014","journal-title":"JAMA"},{"issue":"6","key":"pone.0350982.ref023","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/s41581-022-00540-9","article-title":"The nephropathy of sickle cell trait and sickle cell disease","volume":"18","author":"KI Ataga","year":"2022","journal-title":"Nat Rev Nephrol"},{"issue":"6","key":"pone.0350982.ref024","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/s00705-025-06299-1","article-title":"HPV genotypes in Africa: comprehensive analysis of genetic diversity and evolutionary dynamics","volume":"170","author":"M Allali","year":"2025","journal-title":"Arch Virol"},{"key":"pone.0350982.ref025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/JGO.19.00110","article-title":"Prevalence and distribution of human papillomavirus genotypes among women in Kinshasa, the Democratic Republic of the Congo","volume":"5","author":"AB Mutombo","year":"2019","journal-title":"JGO"},{"issue":"6","key":"pone.0350982.ref026","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3390\/tropicalmed10060157","article-title":"Syndemic synergy of HPV, HIV, and HSV-2 for oncogenic HPV replication in female sex workers","volume":"10","author":"J Muwonga Tukisadila","year":"2025","journal-title":"TropicalMed"},{"issue":"09","key":"pone.0350982.ref027","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.4236\/ojog.2021.119106","article-title":"The place of human papillomavirus test in the screening of intraepithelial lesions of cervix in South-Kivu Province, DR Congo","volume":"11","author":"O Nyakio","year":"2021","journal-title":"OJOG"},{"issue":"1","key":"pone.0350982.ref028","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1472-6874-14-30","article-title":"Knowledge, attitude and practice about cancer of the uterine cervix among women living in Kinshasa, the Democratic Republic of Congo","volume":"14","author":"C Ali-Risasi","year":"2014","journal-title":"BMC Womens Health"},{"key":"pone.0350982.ref029","volume-title":"Strat\u00e9gie nationale de lutte contre les cancers du col ut\u00e9rin et du sein en R\u00e9publique D\u00e9mocratique Du Congo","year":"2015"},{"issue":"1","key":"pone.0350982.ref030","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s41256-024-00380-z","article-title":"Accelerating HPV vaccination in Africa for health equity","volume":"9","author":"E Asempah","year":"2024","journal-title":"Glob Health Res Policy"},{"key":"pone.0350982.ref031","unstructured":"CNRP. Trousses de d\u00e9tection des HPV ayant b\u00e9n\u00e9fici\u00e9 d\u2019une validation clinique pour le d\u00e9pistage du cancer du col de l\u2019ut\u00e9rus. 2024. Accessed 2025 December 10. https:\/\/cnr-hpv.fr\/wp-content\/uploads\/2024\/09"},{"key":"pone.0350982.ref032","unstructured":"Belgium: University Hospital Center of Liege; 2025. https:\/\/www.chuliege.be\/jcms\/c2_18904107\/laboratoire-unilab-lg\/accreditation"},{"key":"pone.0350982.ref033","volume-title":"Enqu\u00eate d\u00e9mographique et de sant\u00e9 de R\u00e9publique D\u00e9mocratique du Congo 2023\u20132024\u00a0: rapport final","author":"RDC-Institut National de la Statistique, \u00c9cole de Sant\u00e9 Publique de Kinshasa, I C F","year":"2025"},{"key":"pone.0350982.ref034","unstructured":"Hologic. ThinPrep\u00ae 5000 Processor. Operator\u2019s Manual. https:\/\/www.hologic.com\/sites\/default\/files\/2021-10\/MAN-06024-001_003_02.pdf"},{"key":"pone.0350982.ref035","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-319-11074-5","volume-title":"The Bethesda system for reporting cervical cytology: definitions, criteria, and explanatory notes","author":"R Nayar","year":"2015","edition":"3"},{"issue":"2","key":"pone.0350982.ref036","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.01239-18","article-title":"Clinical validation of the cobas HPV test on the cobas 6800 system for the purpose of cervical screening","volume":"57","author":"M Saville","year":"2019","journal-title":"J Clin Microbiol"},{"key":"pone.0350982.ref037","first-page":"1","article-title":"Biological agents","volume":"100","author":"IARC Working Group on the Evaluation of Carcinogenic Risks to Humans","year":"2012","journal-title":"IARC Monogr Eval Carcinog Risks Hum"},{"key":"pone.0350982.ref038","article-title":"Nanopore sequencing of high-risk HPV via amplicon and rolling circle amplification points to HPV integration and identifies new HPV types","author":"M Artesia","year":"2026","journal-title":"bioRxiv"},{"issue":"1","key":"pone.0350982.ref039","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/ajh.25305","article-title":"Point-of-care screening for sickle cell disease in low-resource settings: a multi-center evaluation of HemoTypeSC, a novel rapid test","volume":"94","author":"C Steele","year":"2019","journal-title":"Am J Hematol"},{"issue":"12","key":"pone.0350982.ref040","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1373\/clinchem.2008.106369","article-title":"Newborn screening for sickle cell disease using tandem mass spectrometry","volume":"54","author":"F Boemer","year":"2008","journal-title":"Clin Chem"},{"issue":"8","key":"pone.0350982.ref041","doi-asserted-by":"crossref","DOI":"10.1016\/S2214-109X(22)00241-8","article-title":"Cervical cancer screening programmes and age-specific coverage estimates for 202 countries and territories worldwide: a review and synthetic analysis","volume":"10","author":"L Bruni","year":"2022","journal-title":"Lancet Glob Health"},{"issue":"2","key":"pone.0350982.ref042","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/LGT.0000000000000468","article-title":"Guidelines for cervical cancer screening in immunosuppressed women without HIV infection","volume":"23","author":"A-B Moscicki","year":"2019","journal-title":"J Low Genit Tract Dis"},{"issue":"6","key":"pone.0350982.ref043","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1097\/QAD.0000000000001765","article-title":"HIV-positive women have higher risk of HPV infection, precancerous lesions, and cervical cancer: a systematic review and meta-analysis","volume":"32","author":"G Liu","year":"2018","journal-title":"AIDS"},{"key":"pone.0350982.ref044","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s12905-019-0737-y","article-title":"Massive single visit cervical pre-cancer and cancer screening in eastern Democratic Republic of Congo","volume":"19","author":"JL Paluku","year":"2019","journal-title":"BMC Women\u2019s Health"},{"issue":"4","key":"pone.0350982.ref045","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1097\/OLQ.0b013e3181fc6ec0","article-title":"Prevalence and determinants of high-risk human papillomavirus infection in women from a sub-Saharan African community","volume":"38","author":"G Sangwa-Lugoma","year":"2011","journal-title":"Sex Transm Dis"},{"issue":"1","key":"pone.0350982.ref046","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13027-024-00596-1","article-title":"High-risk human papillomavirus genotyping in cervical cancers in Tanzania","volume":"19","author":"G Murenzi","year":"2024","journal-title":"Infect Agent Cancer"},{"issue":"1","key":"pone.0350982.ref047","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/sextrans-2019-054263","article-title":"HPV types, cervical high-grade lesions and risk factors for oncogenic human papillomavirus infection among 3416 Tanzanian women","volume":"97","author":"BL Mchome","year":"2021","journal-title":"Sex Transm Infect"},{"issue":"9","key":"pone.0350982.ref048","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.31557\/APJCP.2021.22.9.2729","article-title":"Racial disparities associated with the prevalence of vaccine and non-vaccine HPV types and multiple HPV infections between Asia and Africa: a systematic review and meta-analysis","volume":"22","author":"JO Okoye","year":"2021","journal-title":"Asian Pac J Cancer Prev"},{"issue":"10","key":"pone.0350982.ref049","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1002\/ijc.33033","article-title":"Association of HPV35 with cervical carcinogenesis among women of African ancestry: evidence of viral-host interaction with implications for disease intervention","volume":"147","author":"M Pinheiro","year":"2020","journal-title":"Int J Cancer"},{"key":"pone.0350982.ref050","volume-title":"Protecting Women and Girls in the Democratic Republic of Congo (DRC) Against Cervical Cancer","author":"M Linda","year":"2025"},{"issue":"1","key":"pone.0350982.ref051","doi-asserted-by":"crossref","first-page":"3679","DOI":"10.1038\/s41467-024-47909-x","article-title":"Concomitant human papillomavirus (HPV) vaccination and screening for elimination of HPV and cervical cancer","volume":"15","author":"LS Arroyo M\u00fchr","year":"2024","journal-title":"Nat Commun"},{"issue":"4","key":"pone.0350982.ref052","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiaf032","article-title":"Population-based age-period-cohort analysis of declining human papillomavirus prevalence","volume":"231","author":"P Gray","year":"2025","journal-title":"J Infect Dis"},{"issue":"1","key":"pone.0350982.ref053","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1186\/s12879-024-10011-0","article-title":"Epidemiological study of human papillomavirus infection in 105,679 women in Wuhan, China","volume":"24","author":"W Guo","year":"2024","journal-title":"BMC Infect Dis"},{"key":"pone.0350982.ref054","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.virol.2013.04.023","article-title":"Cross-roads in the classification of papillomaviruses","volume":"445","author":"E-M de Villiers","year":"2013","journal-title":"Virology"},{"key":"pone.0350982.ref055","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.virusres.2018.03.003","article-title":"Identification and characterization of two novel Gammapapillomavirus genomes in skin of an immunosuppressed Epidermodysplasia Verruciformis patient","volume":"249","author":"S Dutta","year":"2018","journal-title":"Virus Res"},{"issue":"2","key":"pone.0350982.ref056","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.virol.2006.10.022","article-title":"Human papillomavirus (HPV) types 101 and 103 isolated from cervicovaginal cells lack an E6 open reading frame (ORF) and are related to gamma-papillomaviruses","volume":"360","author":"Z Chen","year":"2007","journal-title":"Virology"},{"issue":"8","key":"pone.0350982.ref057","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.29019","article-title":"Prevalence of novel gamma HPV types 223 and 225 in oral cavity and skin of Indian normal and neoplastic participants","volume":"95","author":"N Chatterjee","year":"2023","journal-title":"J Med Virol"},{"key":"pone.0350982.ref058","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.bpobgyn.2017.08.015","article-title":"The natural history of human papillomavirus infection","volume":"47","author":"S de Sanjos\u00e9","year":"2018","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"pone.0350982.ref059","volume-title":"Monographs on the evaluation of carcinogenic risks to humans","author":"IARC working group","year":"2007"},{"issue":"1","key":"pone.0350982.ref060","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1186\/s12879-024-09693-3","article-title":"HPV specificity and multiple infections and association with cervical cytology in Chongqing, China: a cross-sectional study","volume":"24","author":"Q Luo","year":"2024","journal-title":"BMC Infect Dis"},{"issue":"465","key":"pone.0350982.ref061","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S1773-035X(14)72658-9","article-title":"Incidence, persistance et clairance des g\u00e9notypes HPV \u00e0 haut-risque en relation avec le d\u00e9veloppement de l\u00e9sions cervicales, et influence des param\u00e8tres immunologiques dans une cohorte des femmes africaines infect\u00e9es par le VIH-1 (\u00c9tude HARP)","volume":"2014","author":"P Mayaud","year":"2014","journal-title":"Revue Francophone des Laboratoires"},{"issue":"10","key":"pone.0350982.ref062","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.3390\/cancers16101816","article-title":"Extended genotyping to stratify the risk of CIN2+ in women with persistent HPV Infection, negative cytology and Type 3 transformation zone","volume":"16","author":"MT Bruno","year":"2024","journal-title":"Cancers (Basel)"},{"key":"pone.0350982.ref063","doi-asserted-by":"crossref","first-page":"1592395","DOI":"10.3389\/fphar.2025.1592395","article-title":"Curcumin, EGCG and apigenin in cervical cancer: mechanistic insights and therapeutic potential","volume":"16","author":"Sadaf","year":"2025","journal-title":"Front Pharmacol"},{"issue":"12","key":"pone.0350982.ref064","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.3390\/antiox14121469","article-title":"Antioxidant, antimicrobial, and anticancer activity of basil (Ocimum basilicum)","volume":"14","author":"E Poulios","year":"2025","journal-title":"Antioxidants (Basel)"},{"issue":"2","key":"pone.0350982.ref065","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3390\/biom11020219","article-title":"Deeper insights on Alchornea cordifolia (Schumach. & Thonn.) M\u00fcll.Arg extracts: chemical profiles, biological abilities, network analysis and molecular docking","volume":"11","author":"KI Sinan","year":"2021","journal-title":"Biomolecules"},{"issue":"1","key":"pone.0350982.ref066","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/s40168-022-01337-5","article-title":"Lactic acid from vaginal microbiota enhances cervicovaginal epithelial barrier integrity by promoting tight junction protein expression","volume":"10","author":"DJ Delgado-Diaz","year":"2022","journal-title":"Microbiome"},{"issue":"1","key":"pone.0350982.ref067","doi-asserted-by":"crossref","first-page":"11183","DOI":"10.1038\/s41598-024-61942-2","article-title":"Compositional and functional differences of the vaginal microbiota of women with and without cervical dysplasia","volume":"14","author":"J Norenhag","year":"2024","journal-title":"Sci Rep"},{"issue":"2","key":"pone.0350982.ref068","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1128\/CMR.05028-11","article-title":"Epithelial cell responses to infection with human papillomavirus","volume":"25","author":"MA Stanley","year":"2012","journal-title":"Clin Microbiol Rev"},{"key":"pone.0350982.ref069","doi-asserted-by":"crossref","DOI":"10.11604\/pamj.2022.41.250.30950","article-title":"La r\u00e9ponse humorale contre les peptides antig\u00e9niques de Plasmodium falciparum (MSP1, MSP2 et SR-11.1) chez des sujets vivant en zone end\u00e9mique","volume":"41","author":"Y Sourabi\u00e9","year":"2022","journal-title":"Pan Afr Med J"},{"issue":"9","key":"pone.0350982.ref070","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1016\/j.molonc.2015.05.004","article-title":"Identification of major factors associated with failed clinical molecular oncology testing performed by next generation sequencing (NGS)","volume":"9","author":"H Al-Kateb","year":"2015","journal-title":"Mol Oncol"},{"issue":"7","key":"pone.0350982.ref071","article-title":"Quality assurance in cervical cancer screening: evaluation of sample adequacy in HPV DNA testing","volume":"97","author":"M d\u2019Avenia","year":"2025","journal-title":"J Med Virol"},{"issue":"10","key":"pone.0350982.ref072","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0257521","article-title":"Sequencing DNA with nanopores: troubles and biases","volume":"16","author":"C Delahaye","year":"2021","journal-title":"PLoS One"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0350982","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T17:34:05Z","timestamp":1781112845000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0350982"}},"subtitle":[],"editor":[{"given":"Serge","family":"Tonen-Wolyec","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,6,10]]},"references-count":72,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,6,10]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0350982","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,10]]}}}